nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—Triamcinolone—atopic dermatitis	0.0662	0.103	CbGbCtD
Etoricoxib—PTGS2—Betamethasone—atopic dermatitis	0.0568	0.0886	CbGbCtD
Etoricoxib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0434	0.0677	CbGbCtD
Etoricoxib—CYP2C19—Loratadine—atopic dermatitis	0.039	0.0609	CbGbCtD
Etoricoxib—CYP2C19—Diphenhydramine—atopic dermatitis	0.039	0.0609	CbGbCtD
Etoricoxib—CYP1A2—Diphenhydramine—atopic dermatitis	0.036	0.0562	CbGbCtD
Etoricoxib—PTGS2—Dexamethasone—atopic dermatitis	0.033	0.0516	CbGbCtD
Etoricoxib—CYP2C9—Loratadine—atopic dermatitis	0.0325	0.0507	CbGbCtD
Etoricoxib—CYP2C9—Diphenhydramine—atopic dermatitis	0.0325	0.0507	CbGbCtD
Etoricoxib—CYP2D6—Loratadine—atopic dermatitis	0.0297	0.0463	CbGbCtD
Etoricoxib—CYP2D6—Diphenhydramine—atopic dermatitis	0.0297	0.0463	CbGbCtD
Etoricoxib—CYP3A4—Tacrolimus—atopic dermatitis	0.0258	0.0402	CbGbCtD
Etoricoxib—CYP2C19—Prednisone—atopic dermatitis	0.0216	0.0338	CbGbCtD
Etoricoxib—CYP2E1—Dexamethasone—atopic dermatitis	0.0215	0.0336	CbGbCtD
Etoricoxib—CYP3A4—Loratadine—atopic dermatitis	0.0189	0.0295	CbGbCtD
Etoricoxib—CYP3A4—Methylprednisolone—atopic dermatitis	0.0173	0.0269	CbGbCtD
Etoricoxib—CYP2C19—Dexamethasone—atopic dermatitis	0.0135	0.0211	CbGbCtD
Etoricoxib—CYP3A4—Triamcinolone—atopic dermatitis	0.0131	0.0204	CbGbCtD
Etoricoxib—CYP2C9—Dexamethasone—atopic dermatitis	0.0112	0.0175	CbGbCtD
Etoricoxib—CYP3A4—Betamethasone—atopic dermatitis	0.0112	0.0175	CbGbCtD
Etoricoxib—CYP3A4—Prednisolone—atopic dermatitis	0.0111	0.0173	CbGbCtD
Etoricoxib—CYP3A4—Hydrocortisone—atopic dermatitis	0.0105	0.0164	CbGbCtD
Etoricoxib—CYP3A4—Prednisone—atopic dermatitis	0.0105	0.0163	CbGbCtD
Etoricoxib—CYP2D6—Dexamethasone—atopic dermatitis	0.0103	0.016	CbGbCtD
Etoricoxib—CYP3A4—Dexamethasone—atopic dermatitis	0.00653	0.0102	CbGbCtD
Etoricoxib—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.000958	0.165	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.000746	0.128	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.000595	0.102	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000463	0.0797	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.00045	0.0775	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000359	0.0618	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000356	0.0612	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.00035	0.0602	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.00035	0.0602	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.000342	0.0588	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	0.000215	0.0369	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	0.000211	0.0363	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	0.000211	0.0363	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	0.000206	0.0355	CbGdCrCtD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—MAPK8—atopic dermatitis	0.000202	0.00221	CbGpPWpGaD
Etoricoxib—MAPK14—IL-1 signaling pathway—MAPK8—atopic dermatitis	0.000202	0.00221	CbGpPWpGaD
Etoricoxib—MAPK14—RANKL/RANK Signaling Pathway—MAPK8—atopic dermatitis	0.000202	0.00221	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MS4A2—atopic dermatitis	0.000202	0.0022	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—NFKBIA—atopic dermatitis	0.000202	0.0022	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CCL5—atopic dermatitis	0.000201	0.0022	CbGpPWpGaD
Etoricoxib—MAPK14—MAP kinase activation in TLR cascade—MAPK8—atopic dermatitis	0.0002	0.00218	CbGpPWpGaD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—TNF—atopic dermatitis	0.000199	0.00217	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—NFKBIA—atopic dermatitis	0.000197	0.00215	CbGpPWpGaD
Etoricoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000194	0.00212	CbGpPWpGaD
Etoricoxib—PTGS2—Overview of nanoparticle effects—IL6—atopic dermatitis	0.000193	0.00211	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—MAPK8—atopic dermatitis	0.000191	0.00209	CbGpPWpGaD
Etoricoxib—MAPK14—p53 pathway—MAPK8—atopic dermatitis	0.000191	0.00209	CbGpPWpGaD
Etoricoxib—MAPK14—Kit receptor signaling pathway—MAPK8—atopic dermatitis	0.000191	0.00209	CbGpPWpGaD
Etoricoxib—MAPK14—Signalling to RAS—IL6—atopic dermatitis	0.00019	0.00207	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000189	0.00207	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—CASP8—atopic dermatitis	0.000182	0.00199	CbGpPWpGaD
Etoricoxib—MAPK14—Endothelins—MAPK8—atopic dermatitis	0.000182	0.00198	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—NFKBIA—atopic dermatitis	0.000181	0.00198	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—NGF—atopic dermatitis	0.000181	0.00198	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—BDNF—atopic dermatitis	0.00018	0.00197	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IFNG—atopic dermatitis	0.00018	0.00196	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—DEFB1—atopic dermatitis	0.00018	0.00196	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—CASP8—atopic dermatitis	0.000178	0.00194	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—MAPK8—atopic dermatitis	0.000177	0.00193	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—MAPK8—atopic dermatitis	0.000175	0.00191	CbGpPWpGaD
Etoricoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.000173	0.00189	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—MAPK8—atopic dermatitis	0.000173	0.00189	CbGpPWpGaD
Etoricoxib—MAPK14—BCR signaling pathway—MAPK8—atopic dermatitis	0.000173	0.00189	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—IL1B—atopic dermatitis	0.000172	0.00188	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	0.000171	0.00186	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—NFKBIA—atopic dermatitis	0.000171	0.00186	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CXCL10—atopic dermatitis	0.00017	0.00186	CbGpPWpGaD
Etoricoxib—MAPK14—Organelle biogenesis and maintenance—PPARA—atopic dermatitis	0.000168	0.00183	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—CXCL8—atopic dermatitis	0.000167	0.00183	CbGpPWpGaD
Etoricoxib—MAPK14—CDC42 signaling events—MAPK8—atopic dermatitis	0.000167	0.00182	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—CASP8—atopic dermatitis	0.000164	0.00179	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000163	0.00178	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—CD4—atopic dermatitis	0.000161	0.00176	CbGpPWpGaD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—IL6—atopic dermatitis	0.00016	0.00175	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—TNF—atopic dermatitis	0.00016	0.00175	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—NGF—atopic dermatitis	0.00016	0.00175	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL2—atopic dermatitis	0.00016	0.00174	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—KIF3A—atopic dermatitis	0.00016	0.00174	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	0.000159	0.00173	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—MAPK8—atopic dermatitis	0.000158	0.00172	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—MAPK8—atopic dermatitis	0.000158	0.00172	CbGpPWpGaD
Etoricoxib—MAPK14—Signalling to ERKs—IL6—atopic dermatitis	0.000155	0.00169	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—CASP8—atopic dermatitis	0.000154	0.00168	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—NFKBIA—atopic dermatitis	0.000154	0.00168	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—BDNF—atopic dermatitis	0.000153	0.00167	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—CXCL8—atopic dermatitis	0.000153	0.00166	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—NFKBIA—atopic dermatitis	0.000152	0.00166	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	0.000152	0.00166	CbGpPWpGaD
Etoricoxib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00015	0.00163	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—NFKBIA—atopic dermatitis	0.000149	0.00163	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000149	0.00163	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IFNG—atopic dermatitis	0.000148	0.00161	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—MAPK8—atopic dermatitis	0.000147	0.00161	CbGpPWpGaD
Etoricoxib—MAPK14—IL6-mediated signaling events—IL6—atopic dermatitis	0.000147	0.0016	CbGpPWpGaD
Etoricoxib—MAPK14—TSLP Signaling Pathway—IL6—atopic dermatitis	0.000147	0.0016	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—IL2—atopic dermatitis	0.000146	0.00159	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—atopic dermatitis	0.000144	0.00158	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—MAPK8—atopic dermatitis	0.000143	0.00156	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL4—atopic dermatitis	0.000142	0.00155	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK8—atopic dermatitis	0.000142	0.00155	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—CXCL8—atopic dermatitis	0.00014	0.00153	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—MAPK8—atopic dermatitis	0.000139	0.00152	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CASP8—atopic dermatitis	0.000139	0.00151	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—CXCL8—atopic dermatitis	0.000137	0.0015	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—CASP8—atopic dermatitis	0.000137	0.0015	CbGpPWpGaD
Etoricoxib—Angiopathy—Methylprednisolone—atopic dermatitis	0.000137	0.000523	CcSEcCtD
Etoricoxib—MAPK14—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000137	0.00149	CbGpPWpGaD
Etoricoxib—Hallucination—Betamethasone—atopic dermatitis	0.000136	0.000521	CcSEcCtD
Etoricoxib—Hallucination—Dexamethasone—atopic dermatitis	0.000136	0.000521	CcSEcCtD
Etoricoxib—Nausea—Mometasone—atopic dermatitis	0.000136	0.000521	CcSEcCtD
Etoricoxib—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000136	0.00052	CcSEcCtD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	0.000136	0.00149	CbGpPWpGaD
Etoricoxib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000136	0.000519	CcSEcCtD
Etoricoxib—Weight increased—Prednisone—atopic dermatitis	0.000136	0.000519	CcSEcCtD
Etoricoxib—Arrhythmia—Triamcinolone—atopic dermatitis	0.000135	0.000516	CcSEcCtD
Etoricoxib—Vision blurred—Prednisolone—atopic dermatitis	0.000135	0.000515	CcSEcCtD
Etoricoxib—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000135	0.000515	CcSEcCtD
Etoricoxib—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000135	0.000515	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL1B—atopic dermatitis	0.000135	0.00147	CbGpPWpGaD
Etoricoxib—Hyperglycaemia—Prednisone—atopic dermatitis	0.000135	0.000514	CcSEcCtD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—MAPK8—atopic dermatitis	0.000134	0.00146	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—MAPK8—atopic dermatitis	0.000134	0.00146	CbGpPWpGaD
Etoricoxib—Visual impairment—Dexamethasone—atopic dermatitis	0.000132	0.000505	CcSEcCtD
Etoricoxib—Visual impairment—Betamethasone—atopic dermatitis	0.000132	0.000505	CcSEcCtD
Etoricoxib—Mental disorder—Methylprednisolone—atopic dermatitis	0.000132	0.000505	CcSEcCtD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—MAPK8—atopic dermatitis	0.000132	0.00144	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL1B—atopic dermatitis	0.000132	0.00144	CbGpPWpGaD
Etoricoxib—Erythema—Triamcinolone—atopic dermatitis	0.000132	0.000503	CcSEcCtD
Etoricoxib—Erythema—Methylprednisolone—atopic dermatitis	0.000131	0.000502	CcSEcCtD
Etoricoxib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000131	0.000502	CcSEcCtD
Etoricoxib—Asthenia—Tacrolimus—atopic dermatitis	0.000131	0.000501	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000131	0.000501	CcSEcCtD
Etoricoxib—Angioedema—Prednisolone—atopic dermatitis	0.000131	0.000499	CcSEcCtD
Etoricoxib—Myocardial infarction—Prednisone—atopic dermatitis	0.00013	0.000498	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Prednisone—atopic dermatitis	0.00013	0.000498	CcSEcCtD
Etoricoxib—Pruritus—Tacrolimus—atopic dermatitis	0.000129	0.000494	CcSEcCtD
Etoricoxib—Dysgeusia—Triamcinolone—atopic dermatitis	0.000129	0.000492	CcSEcCtD
Etoricoxib—MAPK14—Hemostasis—SELE—atopic dermatitis	0.000129	0.00141	CbGpPWpGaD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—MAPK8—atopic dermatitis	0.000129	0.0014	CbGpPWpGaD
Etoricoxib—Eye disorder—Dexamethasone—atopic dermatitis	0.000128	0.00049	CcSEcCtD
Etoricoxib—Eye disorder—Betamethasone—atopic dermatitis	0.000128	0.00049	CcSEcCtD
Etoricoxib—Angioedema—Hydrocortisone—atopic dermatitis	0.000128	0.000488	CcSEcCtD
Etoricoxib—MAPK14—MAP kinase activation in TLR cascade—IL6—atopic dermatitis	0.000127	0.00139	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—MAPK8—atopic dermatitis	0.000127	0.00138	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FCER1A—atopic dermatitis	0.000126	0.00138	CbGpPWpGaD
Etoricoxib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000125	0.000478	CcSEcCtD
Etoricoxib—Angiopathy—Betamethasone—atopic dermatitis	0.000124	0.000475	CcSEcCtD
Etoricoxib—Angiopathy—Dexamethasone—atopic dermatitis	0.000124	0.000475	CcSEcCtD
Etoricoxib—Hypertension—Prednisolone—atopic dermatitis	0.000124	0.000472	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—MAPK8—atopic dermatitis	0.000124	0.00135	CbGpPWpGaD
Etoricoxib—Arrhythmia—Dexamethasone—atopic dermatitis	0.000123	0.000468	CcSEcCtD
Etoricoxib—Arrhythmia—Betamethasone—atopic dermatitis	0.000123	0.000468	CcSEcCtD
Etoricoxib—MAPK14—Innate Immune System—STAT6—atopic dermatitis	0.000122	0.00133	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—IL6—atopic dermatitis	0.000122	0.00133	CbGpPWpGaD
Etoricoxib—Alopecia—Betamethasone—atopic dermatitis	0.000121	0.000463	CcSEcCtD
Etoricoxib—Alopecia—Dexamethasone—atopic dermatitis	0.000121	0.000463	CcSEcCtD
Etoricoxib—Dizziness—Tacrolimus—atopic dermatitis	0.000121	0.000462	CcSEcCtD
Etoricoxib—Hypertension—Hydrocortisone—atopic dermatitis	0.000121	0.000461	CcSEcCtD
Etoricoxib—Angioedema—Triamcinolone—atopic dermatitis	0.00012	0.000459	CcSEcCtD
Etoricoxib—Haemoglobin—Prednisone—atopic dermatitis	0.00012	0.000459	CcSEcCtD
Etoricoxib—Angioedema—Methylprednisolone—atopic dermatitis	0.00012	0.000458	CcSEcCtD
Etoricoxib—Haemorrhage—Prednisone—atopic dermatitis	0.000119	0.000456	CcSEcCtD
Etoricoxib—Erythema—Betamethasone—atopic dermatitis	0.000119	0.000456	CcSEcCtD
Etoricoxib—Erythema—Dexamethasone—atopic dermatitis	0.000119	0.000456	CcSEcCtD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000119	0.0013	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—CASP8—atopic dermatitis	0.000119	0.0013	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CARD11—atopic dermatitis	0.000119	0.0013	CbGpPWpGaD
Etoricoxib—Hallucination—Prednisone—atopic dermatitis	0.000119	0.000454	CcSEcCtD
Etoricoxib—Anxiety—Hydrocortisone—atopic dermatitis	0.000119	0.000453	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000118	0.000451	CcSEcCtD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	0.000118	0.00129	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MS4A2—atopic dermatitis	0.000118	0.00128	CbGpPWpGaD
Etoricoxib—Connective tissue disorder—Prednisone—atopic dermatitis	0.000117	0.000448	CcSEcCtD
Etoricoxib—Oedema—Prednisolone—atopic dermatitis	0.000117	0.000446	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000117	0.000446	CcSEcCtD
Etoricoxib—Vomiting—Tacrolimus—atopic dermatitis	0.000116	0.000444	CcSEcCtD
Etoricoxib—Rash—Tacrolimus—atopic dermatitis	0.000115	0.00044	CcSEcCtD
Etoricoxib—Dermatitis—Tacrolimus—atopic dermatitis	0.000115	0.00044	CcSEcCtD
Etoricoxib—Shock—Prednisolone—atopic dermatitis	0.000115	0.000439	CcSEcCtD
Etoricoxib—Cough—Triamcinolone—atopic dermatitis	0.000115	0.000439	CcSEcCtD
Etoricoxib—Headache—Tacrolimus—atopic dermatitis	0.000115	0.000438	CcSEcCtD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—atopic dermatitis	0.000114	0.00125	CbGpPWpGaD
Etoricoxib—Oedema—Hydrocortisone—atopic dermatitis	0.000114	0.000436	CcSEcCtD
Etoricoxib—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000114	0.000436	CcSEcCtD
Etoricoxib—MAPK14—Activated TLR4 signalling—MAPK8—atopic dermatitis	0.000114	0.00124	CbGpPWpGaD
Etoricoxib—Hypertension—Triamcinolone—atopic dermatitis	0.000114	0.000434	CcSEcCtD
Etoricoxib—Hypertension—Methylprednisolone—atopic dermatitis	0.000113	0.000433	CcSEcCtD
Etoricoxib—Infection—Hydrocortisone—atopic dermatitis	0.000113	0.000433	CcSEcCtD
Etoricoxib—Shock—Hydrocortisone—atopic dermatitis	0.000112	0.000429	CcSEcCtD
Etoricoxib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000112	0.000427	CcSEcCtD
Etoricoxib—Arthralgia—Methylprednisolone—atopic dermatitis	0.000112	0.000427	CcSEcCtD
Etoricoxib—Eye disorder—Prednisone—atopic dermatitis	0.000112	0.000426	CcSEcCtD
Etoricoxib—Anxiety—Methylprednisolone—atopic dermatitis	0.000111	0.000426	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000111	0.000424	CcSEcCtD
Etoricoxib—Flushing—Prednisone—atopic dermatitis	0.000111	0.000423	CcSEcCtD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000111	0.00121	CbGpPWpGaD
Etoricoxib—Skin disorder—Hydrocortisone—atopic dermatitis	0.000111	0.000423	CcSEcCtD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	0.00011	0.00121	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	0.00011	0.0012	CbGpPWpGaD
Etoricoxib—Dry mouth—Triamcinolone—atopic dermatitis	0.00011	0.000419	CcSEcCtD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—MAPK8—atopic dermatitis	0.000109	0.00119	CbGpPWpGaD
Etoricoxib—Angioedema—Dexamethasone—atopic dermatitis	0.000109	0.000417	CcSEcCtD
Etoricoxib—Angioedema—Betamethasone—atopic dermatitis	0.000109	0.000417	CcSEcCtD
Etoricoxib—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	0.000109	0.00119	CbGpPWpGaD
Etoricoxib—Anorexia—Hydrocortisone—atopic dermatitis	0.000109	0.000415	CcSEcCtD
Etoricoxib—Nausea—Tacrolimus—atopic dermatitis	0.000109	0.000415	CcSEcCtD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000109	0.00119	CbGpPWpGaD
Etoricoxib—Angiopathy—Prednisone—atopic dermatitis	0.000108	0.000414	CcSEcCtD
Etoricoxib—Confusional state—Methylprednisolone—atopic dermatitis	0.000108	0.000413	CcSEcCtD
Etoricoxib—Immune system disorder—Prednisone—atopic dermatitis	0.000108	0.000412	CcSEcCtD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000108	0.00117	CbGpPWpGaD
Etoricoxib—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000107	0.00041	CcSEcCtD
Etoricoxib—Oedema—Triamcinolone—atopic dermatitis	0.000107	0.00041	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000107	0.000409	CcSEcCtD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	0.000107	0.00117	CbGpPWpGaD
Etoricoxib—Arrhythmia—Prednisone—atopic dermatitis	0.000107	0.000408	CcSEcCtD
Etoricoxib—Infection—Triamcinolone—atopic dermatitis	0.000107	0.000408	CcSEcCtD
Etoricoxib—Infection—Methylprednisolone—atopic dermatitis	0.000106	0.000407	CcSEcCtD
Etoricoxib—Shock—Triamcinolone—atopic dermatitis	0.000106	0.000404	CcSEcCtD
Etoricoxib—Insomnia—Prednisolone—atopic dermatitis	0.000106	0.000404	CcSEcCtD
Etoricoxib—Alopecia—Prednisone—atopic dermatitis	0.000106	0.000403	CcSEcCtD
Etoricoxib—Shock—Methylprednisolone—atopic dermatitis	0.000105	0.000403	CcSEcCtD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	0.000105	0.00115	CbGpPWpGaD
Etoricoxib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000105	0.000401	CcSEcCtD
Etoricoxib—MAPK14—Immune System—DEFB1—atopic dermatitis	0.000105	0.00114	CbGpPWpGaD
Etoricoxib—Mental disorder—Prednisone—atopic dermatitis	0.000105	0.0004	CcSEcCtD
Etoricoxib—MAPK14—Signaling by NGF—NGF—atopic dermatitis	0.000105	0.00114	CbGpPWpGaD
Etoricoxib—Skin disorder—Methylprednisolone—atopic dermatitis	0.000104	0.000398	CcSEcCtD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000104	0.00114	CbGpPWpGaD
Etoricoxib—Erythema—Prednisone—atopic dermatitis	0.000104	0.000397	CcSEcCtD
Etoricoxib—Malnutrition—Prednisone—atopic dermatitis	0.000104	0.000397	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000104	0.000397	CcSEcCtD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000103	0.00113	CbGpPWpGaD
Etoricoxib—Insomnia—Hydrocortisone—atopic dermatitis	0.000103	0.000394	CcSEcCtD
Etoricoxib—Hypertension—Dexamethasone—atopic dermatitis	0.000103	0.000394	CcSEcCtD
Etoricoxib—Hypertension—Betamethasone—atopic dermatitis	0.000103	0.000394	CcSEcCtD
Etoricoxib—MAPK14—Cell-Cell communication—MAPK8—atopic dermatitis	0.000102	0.00111	CbGpPWpGaD
Etoricoxib—Anxiety—Dexamethasone—atopic dermatitis	0.000101	0.000387	CcSEcCtD
Etoricoxib—Anxiety—Betamethasone—atopic dermatitis	0.000101	0.000387	CcSEcCtD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	0.000101	0.0011	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—MAPK8—atopic dermatitis	0.000101	0.0011	CbGpPWpGaD
Etoricoxib—Dyspepsia—Hydrocortisone—atopic dermatitis	0.0001	0.000384	CcSEcCtD
Etoricoxib—Pain—Prednisolone—atopic dermatitis	9.99e-05	0.000382	CcSEcCtD
Etoricoxib—Decreased appetite—Hydrocortisone—atopic dermatitis	9.92e-05	0.000379	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	9.85e-05	0.000376	CcSEcCtD
Etoricoxib—Fatigue—Hydrocortisone—atopic dermatitis	9.84e-05	0.000376	CcSEcCtD
Etoricoxib—Vision blurred—Prednisone—atopic dermatitis	9.8e-05	0.000374	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	9.79e-05	0.000374	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	9.77e-05	0.00107	CbGpPWpGaD
Etoricoxib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	9.76e-05	0.000373	CcSEcCtD
Etoricoxib—Pain—Hydrocortisone—atopic dermatitis	9.76e-05	0.000373	CcSEcCtD
Etoricoxib—MAPK14—Hemostasis—IL5—atopic dermatitis	9.75e-05	0.00106	CbGpPWpGaD
Etoricoxib—Anaphylactic shock—Betamethasone—atopic dermatitis	9.75e-05	0.000372	CcSEcCtD
Etoricoxib—Anaphylactic shock—Dexamethasone—atopic dermatitis	9.75e-05	0.000372	CcSEcCtD
Etoricoxib—Oedema—Betamethasone—atopic dermatitis	9.75e-05	0.000372	CcSEcCtD
Etoricoxib—Oedema—Dexamethasone—atopic dermatitis	9.75e-05	0.000372	CcSEcCtD
Etoricoxib—Insomnia—Triamcinolone—atopic dermatitis	9.72e-05	0.000371	CcSEcCtD
Etoricoxib—Insomnia—Methylprednisolone—atopic dermatitis	9.69e-05	0.00037	CcSEcCtD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	9.68e-05	0.00106	CbGpPWpGaD
Etoricoxib—Infection—Betamethasone—atopic dermatitis	9.68e-05	0.00037	CcSEcCtD
Etoricoxib—Infection—Dexamethasone—atopic dermatitis	9.68e-05	0.00037	CcSEcCtD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	9.64e-05	0.00105	CbGpPWpGaD
Etoricoxib—Feeling abnormal—Prednisolone—atopic dermatitis	9.63e-05	0.000368	CcSEcCtD
Etoricoxib—Anaemia—Prednisone—atopic dermatitis	9.61e-05	0.000367	CcSEcCtD
Etoricoxib—Shock—Betamethasone—atopic dermatitis	9.59e-05	0.000366	CcSEcCtD
Etoricoxib—Shock—Dexamethasone—atopic dermatitis	9.59e-05	0.000366	CcSEcCtD
Etoricoxib—Dyspnoea—Triamcinolone—atopic dermatitis	9.58e-05	0.000366	CcSEcCtD
Etoricoxib—Nervous system disorder—Dexamethasone—atopic dermatitis	9.56e-05	0.000365	CcSEcCtD
Etoricoxib—Nervous system disorder—Betamethasone—atopic dermatitis	9.56e-05	0.000365	CcSEcCtD
Etoricoxib—Agitation—Prednisone—atopic dermatitis	9.56e-05	0.000365	CcSEcCtD
Etoricoxib—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.54e-05	0.000364	CcSEcCtD
Etoricoxib—Thrombocytopenia—Betamethasone—atopic dermatitis	9.54e-05	0.000364	CcSEcCtD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	9.53e-05	0.00104	CbGpPWpGaD
Etoricoxib—Angioedema—Prednisone—atopic dermatitis	9.5e-05	0.000363	CcSEcCtD
Etoricoxib—Dyspepsia—Triamcinolone—atopic dermatitis	9.46e-05	0.000361	CcSEcCtD
Etoricoxib—Dyspepsia—Methylprednisolone—atopic dermatitis	9.43e-05	0.00036	CcSEcCtD
Etoricoxib—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.4e-05	0.000359	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	9.39e-05	0.00103	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—MAPK8—atopic dermatitis	9.37e-05	0.00102	CbGpPWpGaD
Etoricoxib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	9.33e-05	0.000356	CcSEcCtD
Etoricoxib—Anorexia—Dexamethasone—atopic dermatitis	9.29e-05	0.000355	CcSEcCtD
Etoricoxib—Anorexia—Betamethasone—atopic dermatitis	9.29e-05	0.000355	CcSEcCtD
Etoricoxib—Urticaria—Prednisolone—atopic dermatitis	9.28e-05	0.000354	CcSEcCtD
Etoricoxib—MAPK14—Innate Immune System—CASP1—atopic dermatitis	9.26e-05	0.00101	CbGpPWpGaD
Etoricoxib—Fatigue—Triamcinolone—atopic dermatitis	9.26e-05	0.000354	CcSEcCtD
Etoricoxib—Fatigue—Methylprednisolone—atopic dermatitis	9.24e-05	0.000353	CcSEcCtD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	9.21e-05	0.00101	CbGpPWpGaD
Etoricoxib—Pain—Triamcinolone—atopic dermatitis	9.19e-05	0.000351	CcSEcCtD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	9.17e-05	0.001	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	9.13e-05	0.000996	CbGpPWpGaD
Etoricoxib—Urticaria—Hydrocortisone—atopic dermatitis	9.06e-05	0.000346	CcSEcCtD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	9.04e-05	0.000987	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—IL1B—atopic dermatitis	9.04e-05	0.000987	CbGpPWpGaD
Etoricoxib—Abdominal pain—Hydrocortisone—atopic dermatitis	9.02e-05	0.000344	CcSEcCtD
Etoricoxib—Hypertension—Prednisone—atopic dermatitis	8.98e-05	0.000343	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	8.88e-05	0.000339	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	8.88e-05	0.000339	CcSEcCtD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	8.88e-05	0.000969	CbGpPWpGaD
Etoricoxib—Arthralgia—Prednisone—atopic dermatitis	8.85e-05	0.000338	CcSEcCtD
Etoricoxib—Feeling abnormal—Triamcinolone—atopic dermatitis	8.85e-05	0.000338	CcSEcCtD
Etoricoxib—Feeling abnormal—Methylprednisolone—atopic dermatitis	8.83e-05	0.000337	CcSEcCtD
Etoricoxib—Anxiety—Prednisone—atopic dermatitis	8.82e-05	0.000337	CcSEcCtD
Etoricoxib—Insomnia—Dexamethasone—atopic dermatitis	8.82e-05	0.000337	CcSEcCtD
Etoricoxib—Insomnia—Betamethasone—atopic dermatitis	8.82e-05	0.000337	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	8.79e-05	0.000336	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.76e-05	0.000335	CcSEcCtD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL6—atopic dermatitis	8.72e-05	0.000952	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CXCL8—atopic dermatitis	8.68e-05	0.000948	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—NFKBIA—atopic dermatitis	8.63e-05	0.000942	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—MAPK8—atopic dermatitis	8.62e-05	0.000941	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Prednisolone—atopic dermatitis	8.61e-05	0.000329	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	8.59e-05	0.000937	CbGpPWpGaD
Etoricoxib—Dyspepsia—Dexamethasone—atopic dermatitis	8.58e-05	0.000328	CcSEcCtD
Etoricoxib—Dyspepsia—Betamethasone—atopic dermatitis	8.58e-05	0.000328	CcSEcCtD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	8.57e-05	0.000935	CbGpPWpGaD
Etoricoxib—Urticaria—Triamcinolone—atopic dermatitis	8.53e-05	0.000326	CcSEcCtD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	8.53e-05	0.000931	CbGpPWpGaD
Etoricoxib—Urticaria—Methylprednisolone—atopic dermatitis	8.51e-05	0.000325	CcSEcCtD
Etoricoxib—Oedema—Prednisone—atopic dermatitis	8.49e-05	0.000324	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisone—atopic dermatitis	8.49e-05	0.000324	CcSEcCtD
Etoricoxib—Abdominal pain—Methylprednisolone—atopic dermatitis	8.47e-05	0.000324	CcSEcCtD
Etoricoxib—Decreased appetite—Dexamethasone—atopic dermatitis	8.47e-05	0.000324	CcSEcCtD
Etoricoxib—Decreased appetite—Betamethasone—atopic dermatitis	8.47e-05	0.000324	CcSEcCtD
Etoricoxib—Infection—Prednisone—atopic dermatitis	8.43e-05	0.000322	CcSEcCtD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	8.42e-05	0.000919	CbGpPWpGaD
Etoricoxib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	8.41e-05	0.000321	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	8.41e-05	0.000321	CcSEcCtD
Etoricoxib—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.4e-05	0.000321	CcSEcCtD
Etoricoxib—Fatigue—Dexamethasone—atopic dermatitis	8.4e-05	0.000321	CcSEcCtD
Etoricoxib—Fatigue—Betamethasone—atopic dermatitis	8.4e-05	0.000321	CcSEcCtD
Etoricoxib—MAPK14—Innate Immune System—TLR2—atopic dermatitis	8.38e-05	0.000915	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KIF3A—atopic dermatitis	8.37e-05	0.000914	CbGpPWpGaD
Etoricoxib—Shock—Prednisone—atopic dermatitis	8.35e-05	0.000319	CcSEcCtD
Etoricoxib—Pain—Betamethasone—atopic dermatitis	8.33e-05	0.000318	CcSEcCtD
Etoricoxib—Pain—Dexamethasone—atopic dermatitis	8.33e-05	0.000318	CcSEcCtD
Etoricoxib—Nervous system disorder—Prednisone—atopic dermatitis	8.32e-05	0.000318	CcSEcCtD
Etoricoxib—MAPK14—MAPK Signaling Pathway—MAPK8—atopic dermatitis	8.29e-05	0.000905	CbGpPWpGaD
Etoricoxib—Skin disorder—Prednisone—atopic dermatitis	8.24e-05	0.000315	CcSEcCtD
Etoricoxib—Asthenia—Hydrocortisone—atopic dermatitis	8.18e-05	0.000313	CcSEcCtD
Etoricoxib—MAPK14—Signaling Pathways—FCER2—atopic dermatitis	8.17e-05	0.000892	CbGpPWpGaD
Etoricoxib—Anorexia—Prednisone—atopic dermatitis	8.09e-05	0.000309	CcSEcCtD
Etoricoxib—MAPK14—MyD88-independent cascade—IL6—atopic dermatitis	8.08e-05	0.000882	CbGpPWpGaD
Etoricoxib—Pruritus—Hydrocortisone—atopic dermatitis	8.07e-05	0.000308	CcSEcCtD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.05e-05	0.000879	CbGpPWpGaD
Etoricoxib—Feeling abnormal—Betamethasone—atopic dermatitis	8.03e-05	0.000307	CcSEcCtD
Etoricoxib—Feeling abnormal—Dexamethasone—atopic dermatitis	8.03e-05	0.000307	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	7.98e-05	0.000872	CbGpPWpGaD
Etoricoxib—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.97e-05	0.000304	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.97e-05	0.000304	CcSEcCtD
Etoricoxib—Hypersensitivity—Triamcinolone—atopic dermatitis	7.91e-05	0.000302	CcSEcCtD
Etoricoxib—Hypersensitivity—Methylprednisolone—atopic dermatitis	7.9e-05	0.000302	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	7.89e-05	0.000861	CbGpPWpGaD
Etoricoxib—Diarrhoea—Hydrocortisone—atopic dermatitis	7.81e-05	0.000298	CcSEcCtD
Etoricoxib—Urticaria—Dexamethasone—atopic dermatitis	7.74e-05	0.000296	CcSEcCtD
Etoricoxib—Urticaria—Betamethasone—atopic dermatitis	7.74e-05	0.000296	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	7.73e-05	0.000295	CcSEcCtD
Etoricoxib—Dizziness—Prednisolone—atopic dermatitis	7.72e-05	0.000295	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	7.71e-05	0.000841	CbGpPWpGaD
Etoricoxib—Asthenia—Triamcinolone—atopic dermatitis	7.71e-05	0.000294	CcSEcCtD
Etoricoxib—Abdominal pain—Dexamethasone—atopic dermatitis	7.7e-05	0.000294	CcSEcCtD
Etoricoxib—Abdominal pain—Betamethasone—atopic dermatitis	7.7e-05	0.000294	CcSEcCtD
Etoricoxib—Asthenia—Methylprednisolone—atopic dermatitis	7.69e-05	0.000294	CcSEcCtD
Etoricoxib—Insomnia—Prednisone—atopic dermatitis	7.68e-05	0.000293	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	7.66e-05	0.000836	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—MAPK8—atopic dermatitis	7.64e-05	0.000834	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	7.63e-05	0.000833	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	7.63e-05	0.000833	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	7.62e-05	0.000831	CbGpPWpGaD
Etoricoxib—Pruritus—Triamcinolone—atopic dermatitis	7.6e-05	0.00029	CcSEcCtD
Etoricoxib—MAPK14—Signaling Pathways—CCL22—atopic dermatitis	7.6e-05	0.000829	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	7.59e-05	0.000829	CbGpPWpGaD
Etoricoxib—Pruritus—Methylprednisolone—atopic dermatitis	7.58e-05	0.00029	CcSEcCtD
Etoricoxib—Dizziness—Hydrocortisone—atopic dermatitis	7.54e-05	0.000288	CcSEcCtD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	7.48e-05	0.000816	CbGpPWpGaD
Etoricoxib—Dyspepsia—Prednisone—atopic dermatitis	7.47e-05	0.000285	CcSEcCtD
Etoricoxib—Decreased appetite—Prednisone—atopic dermatitis	7.38e-05	0.000282	CcSEcCtD
Etoricoxib—Rash—Prednisolone—atopic dermatitis	7.36e-05	0.000281	CcSEcCtD
Etoricoxib—Dermatitis—Prednisolone—atopic dermatitis	7.36e-05	0.000281	CcSEcCtD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	7.34e-05	0.000801	CbGpPWpGaD
Etoricoxib—Diarrhoea—Methylprednisolone—atopic dermatitis	7.33e-05	0.00028	CcSEcCtD
Etoricoxib—Fatigue—Prednisone—atopic dermatitis	7.32e-05	0.00028	CcSEcCtD
Etoricoxib—Headache—Prednisolone—atopic dermatitis	7.32e-05	0.000279	CcSEcCtD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—atopic dermatitis	7.27e-05	0.000793	CbGpPWpGaD
Etoricoxib—Constipation—Prednisone—atopic dermatitis	7.26e-05	0.000277	CcSEcCtD
Etoricoxib—Vomiting—Hydrocortisone—atopic dermatitis	7.25e-05	0.000277	CcSEcCtD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	7.23e-05	0.000789	CbGpPWpGaD
Etoricoxib—Rash—Hydrocortisone—atopic dermatitis	7.19e-05	0.000275	CcSEcCtD
Etoricoxib—Dermatitis—Hydrocortisone—atopic dermatitis	7.19e-05	0.000274	CcSEcCtD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—atopic dermatitis	7.17e-05	0.000782	CbGpPWpGaD
Etoricoxib—Headache—Hydrocortisone—atopic dermatitis	7.15e-05	0.000273	CcSEcCtD
Etoricoxib—MAPK14—Immune System—STAT6—atopic dermatitis	7.12e-05	0.000777	CbGpPWpGaD
Etoricoxib—Dizziness—Triamcinolone—atopic dermatitis	7.1e-05	0.000271	CcSEcCtD
Etoricoxib—Dizziness—Methylprednisolone—atopic dermatitis	7.09e-05	0.000271	CcSEcCtD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	7.03e-05	0.000767	CbGpPWpGaD
Etoricoxib—Feeling abnormal—Prednisone—atopic dermatitis	6.99e-05	0.000267	CcSEcCtD
Etoricoxib—Asthenia—Betamethasone—atopic dermatitis	6.99e-05	0.000267	CcSEcCtD
Etoricoxib—Asthenia—Dexamethasone—atopic dermatitis	6.99e-05	0.000267	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Prednisone—atopic dermatitis	6.94e-05	0.000265	CcSEcCtD
Etoricoxib—Nausea—Prednisolone—atopic dermatitis	6.94e-05	0.000265	CcSEcCtD
Etoricoxib—MAPK14—Immune System—CARD11—atopic dermatitis	6.93e-05	0.000756	CbGpPWpGaD
Etoricoxib—Pruritus—Dexamethasone—atopic dermatitis	6.9e-05	0.000263	CcSEcCtD
Etoricoxib—Pruritus—Betamethasone—atopic dermatitis	6.9e-05	0.000263	CcSEcCtD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	6.87e-05	0.00075	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	6.84e-05	0.000746	CbGpPWpGaD
Etoricoxib—Vomiting—Triamcinolone—atopic dermatitis	6.83e-05	0.000261	CcSEcCtD
Etoricoxib—Vomiting—Methylprednisolone—atopic dermatitis	6.81e-05	0.00026	CcSEcCtD
Etoricoxib—Nausea—Hydrocortisone—atopic dermatitis	6.78e-05	0.000259	CcSEcCtD
Etoricoxib—Rash—Triamcinolone—atopic dermatitis	6.77e-05	0.000259	CcSEcCtD
Etoricoxib—MAPK14—Signaling Pathways—CCL27—atopic dermatitis	6.77e-05	0.000739	CbGpPWpGaD
Etoricoxib—Dermatitis—Triamcinolone—atopic dermatitis	6.77e-05	0.000258	CcSEcCtD
Etoricoxib—Rash—Methylprednisolone—atopic dermatitis	6.76e-05	0.000258	CcSEcCtD
Etoricoxib—Dermatitis—Methylprednisolone—atopic dermatitis	6.75e-05	0.000258	CcSEcCtD
Etoricoxib—Urticaria—Prednisone—atopic dermatitis	6.74e-05	0.000258	CcSEcCtD
Etoricoxib—Headache—Triamcinolone—atopic dermatitis	6.73e-05	0.000257	CcSEcCtD
Etoricoxib—Headache—Methylprednisolone—atopic dermatitis	6.71e-05	0.000256	CcSEcCtD
Etoricoxib—Abdominal pain—Prednisone—atopic dermatitis	6.71e-05	0.000256	CcSEcCtD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	6.68e-05	0.000729	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	6.68e-05	0.000729	CbGpPWpGaD
Etoricoxib—Diarrhoea—Betamethasone—atopic dermatitis	6.67e-05	0.000255	CcSEcCtD
Etoricoxib—Diarrhoea—Dexamethasone—atopic dermatitis	6.67e-05	0.000255	CcSEcCtD
Etoricoxib—MAPK14—Cellular responses to stress—CXCL8—atopic dermatitis	6.56e-05	0.000716	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—atopic dermatitis	6.56e-05	0.000716	CbGpPWpGaD
Etoricoxib—Dizziness—Dexamethasone—atopic dermatitis	6.44e-05	0.000246	CcSEcCtD
Etoricoxib—Dizziness—Betamethasone—atopic dermatitis	6.44e-05	0.000246	CcSEcCtD
Etoricoxib—Nausea—Triamcinolone—atopic dermatitis	6.38e-05	0.000244	CcSEcCtD
Etoricoxib—Nausea—Methylprednisolone—atopic dermatitis	6.37e-05	0.000243	CcSEcCtD
Etoricoxib—MAPK14—Developmental Biology—PPARA—atopic dermatitis	6.3e-05	0.000688	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.27e-05	0.000685	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Prednisone—atopic dermatitis	6.25e-05	0.000239	CcSEcCtD
Etoricoxib—Vomiting—Dexamethasone—atopic dermatitis	6.2e-05	0.000237	CcSEcCtD
Etoricoxib—Vomiting—Betamethasone—atopic dermatitis	6.2e-05	0.000237	CcSEcCtD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	6.16e-05	0.000672	CbGpPWpGaD
Etoricoxib—Rash—Betamethasone—atopic dermatitis	6.15e-05	0.000235	CcSEcCtD
Etoricoxib—Rash—Dexamethasone—atopic dermatitis	6.15e-05	0.000235	CcSEcCtD
Etoricoxib—Dermatitis—Dexamethasone—atopic dermatitis	6.14e-05	0.000235	CcSEcCtD
Etoricoxib—Dermatitis—Betamethasone—atopic dermatitis	6.14e-05	0.000235	CcSEcCtD
Etoricoxib—Headache—Betamethasone—atopic dermatitis	6.11e-05	0.000233	CcSEcCtD
Etoricoxib—Headache—Dexamethasone—atopic dermatitis	6.11e-05	0.000233	CcSEcCtD
Etoricoxib—Asthenia—Prednisone—atopic dermatitis	6.09e-05	0.000233	CcSEcCtD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—atopic dermatitis	6.09e-05	0.000665	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL17—atopic dermatitis	6.07e-05	0.000663	CbGpPWpGaD
Etoricoxib—Pruritus—Prednisone—atopic dermatitis	6.01e-05	0.000229	CcSEcCtD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	5.92e-05	0.000646	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—GLB1—atopic dermatitis	5.89e-05	0.000643	CbGpPWpGaD
Etoricoxib—Diarrhoea—Prednisone—atopic dermatitis	5.81e-05	0.000222	CcSEcCtD
Etoricoxib—Nausea—Dexamethasone—atopic dermatitis	5.79e-05	0.000221	CcSEcCtD
Etoricoxib—Nausea—Betamethasone—atopic dermatitis	5.79e-05	0.000221	CcSEcCtD
Etoricoxib—MAPK14—Cellular responses to stress—MAPK8—atopic dermatitis	5.77e-05	0.00063	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	5.67e-05	0.000619	CbGpPWpGaD
Etoricoxib—Dizziness—Prednisone—atopic dermatitis	5.61e-05	0.000214	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	5.56e-05	0.000607	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—MAPK8—atopic dermatitis	5.41e-05	0.000591	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KIF3A—atopic dermatitis	5.41e-05	0.000591	CbGpPWpGaD
Etoricoxib—Vomiting—Prednisone—atopic dermatitis	5.4e-05	0.000206	CcSEcCtD
Etoricoxib—MAPK14—Immune System—CASP1—atopic dermatitis	5.4e-05	0.000589	CbGpPWpGaD
Etoricoxib—Rash—Prednisone—atopic dermatitis	5.35e-05	0.000204	CcSEcCtD
Etoricoxib—Dermatitis—Prednisone—atopic dermatitis	5.35e-05	0.000204	CcSEcCtD
Etoricoxib—Headache—Prednisone—atopic dermatitis	5.32e-05	0.000203	CcSEcCtD
Etoricoxib—MAPK14—Immune System—IL5—atopic dermatitis	5.11e-05	0.000558	CbGpPWpGaD
Etoricoxib—Nausea—Prednisone—atopic dermatitis	5.04e-05	0.000193	CcSEcCtD
Etoricoxib—PTGS2—Metabolism—GLB1—atopic dermatitis	4.94e-05	0.000539	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NFKBIA—atopic dermatitis	4.92e-05	0.000537	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CMA1—atopic dermatitis	4.9e-05	0.000534	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL11—atopic dermatitis	4.9e-05	0.000534	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR2—atopic dermatitis	4.88e-05	0.000533	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—atopic dermatitis	4.88e-05	0.000533	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	4.78e-05	0.000522	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ADSL—atopic dermatitis	4.73e-05	0.000517	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GLB1—atopic dermatitis	4.65e-05	0.000507	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT6—atopic dermatitis	4.6e-05	0.000502	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD79A—atopic dermatitis	4.59e-05	0.000501	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	4.5e-05	0.000491	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	4.48e-05	0.00049	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ADSL—atopic dermatitis	4.45e-05	0.000486	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CASP8—atopic dermatitis	4.44e-05	0.000485	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR3—atopic dermatitis	3.99e-05	0.000436	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC11A1—atopic dermatitis	3.95e-05	0.000431	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.78e-05	0.000413	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL18—atopic dermatitis	3.75e-05	0.00041	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—atopic dermatitis	3.73e-05	0.000407	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD8A—atopic dermatitis	3.7e-05	0.000404	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—atopic dermatitis	3.69e-05	0.000402	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—atopic dermatitis	3.65e-05	0.000398	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.6e-05	0.000393	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GLB1—atopic dermatitis	3.58e-05	0.000391	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TAC1—atopic dermatitis	3.56e-05	0.000388	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NPS—atopic dermatitis	3.56e-05	0.000388	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCR3—atopic dermatitis	3.49e-05	0.000381	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—atopic dermatitis	3.46e-05	0.000377	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ADSL—atopic dermatitis	3.44e-05	0.000375	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL5—atopic dermatitis	3.31e-05	0.000361	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GLB1—atopic dermatitis	3.3e-05	0.00036	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GLB1—atopic dermatitis	3.27e-05	0.000357	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PPARA—atopic dermatitis	3.22e-05	0.000352	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ADSL—atopic dermatitis	3.16e-05	0.000345	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ADSL—atopic dermatitis	3.13e-05	0.000342	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MAPK8—atopic dermatitis	3.09e-05	0.000337	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NFKBIA—atopic dermatitis	2.87e-05	0.000313	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL10—atopic dermatitis	2.82e-05	0.000308	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GLB1—atopic dermatitis	2.79e-05	0.000305	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—atopic dermatitis	2.77e-05	0.000302	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ADSL—atopic dermatitis	2.68e-05	0.000292	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.61e-05	0.000285	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CASP8—atopic dermatitis	2.59e-05	0.000282	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL5—atopic dermatitis	2.43e-05	0.000265	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.38e-05	0.00026	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NGF—atopic dermatitis	2.25e-05	0.000245	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—atopic dermatitis	2.23e-05	0.000244	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNG—atopic dermatitis	2.2e-05	0.00024	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR5—atopic dermatitis	2.19e-05	0.000239	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.16e-05	0.000235	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—atopic dermatitis	2.12e-05	0.000232	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.07e-05	0.000226	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.04e-05	0.000222	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CCR5—atopic dermatitis	1.99e-05	0.000218	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—atopic dermatitis	1.97e-05	0.000215	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—atopic dermatitis	1.96e-05	0.000214	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—atopic dermatitis	1.95e-05	0.000213	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NFKBIA—atopic dermatitis	1.85e-05	0.000202	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK8—atopic dermatitis	1.8e-05	0.000196	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARA—atopic dermatitis	1.6e-05	0.000175	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARA—atopic dermatitis	1.51e-05	0.000165	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—atopic dermatitis	1.32e-05	0.000144	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—atopic dermatitis	1.26e-05	0.000138	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—atopic dermatitis	1.25e-05	0.000137	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARA—atopic dermatitis	1.16e-05	0.000127	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK8—atopic dermatitis	1.16e-05	0.000127	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—atopic dermatitis	1.15e-05	0.000125	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.07e-05	0.000117	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.06e-05	0.000116	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARA—atopic dermatitis	9.06e-06	9.89e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—atopic dermatitis	7.43e-06	8.11e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARA—atopic dermatitis	6.99e-06	7.64e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—atopic dermatitis	6.77e-06	7.4e-05	CbGpPWpGaD
